Predictors of Significant Disease Activity Score-28 (Using C-reactive protein) Remission Achieved with Intravenous Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial

被引：0
|
作者：
Bingham, Clifton O., III [1 ]
Weinblatt, Michael [2 ]
Mendelsohn, Alan [3 ]
Kim, Lilianne [3 ]
Mack, Michael [3 ]
Lu, Jiandong [3 ]
Baker, Daniel [3 ]
Westhovens, Rene [4 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Janssen Res & Dev LLC, Spring House, PA USA
[4] Univ Hosp KU Leuven, Louvain, Belgium
来源：
ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1301
引用
收藏
页码：S558 / S558
页数：1
相关论文
共 50 条
  • [1] PREDICTORS OF SIGNIFICANT DISEASE ACTIVITY SCORE-28 (USING C-REACTIVE PROTEIN) REMISSION ACHIEVED WITH INTRAVENOUS GOLIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY: RESULTS OF THE PHASE III, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Bingham, Clifton O.
    Weinblatt, Michael E.
    Mendelsohn, Alan
    Kim, Lilianne
    Mack, Michael
    Lu, Jiandong
    Baker, Daniel
    Westhovens, Rene
    RHEUMATOLOGY, 2013, 52 : 82 - 83
  • [2] INTRAVENOUS GOLIMUMAB IS EFFECTIVE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY WITH RESULTS OBSERVED BY 2 WEEKS: RESULTS OF THE PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Weinblatt, M. E.
    Bingham, C. O., III
    Mendelsohn, A. M.
    Kim, L.
    Mack, M.
    Lu, J.
    Baker, D.
    Westhovens, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 368 - 369
  • [3] Sustained and Consistent Clinical Benefit With Intravenous Golimumab Therapy In Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results Through 1-Year Of a Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
    Bingham, Clifton O., III
    Westhovens, Rene
    Mendelsohn, Alan M.
    Kim, Lilianne
    Lo, Kim Hung
    Weinblatt, Michael E.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S374 - S374
  • [4] Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial
    Weinblatt, Michael E.
    Bingham, Clifton O., III
    Mendelsohn, Alan M.
    Kim, Lilianne
    Mack, Michael
    Lu, Jiandong
    Baker, Daniel
    Westhovens, Rene
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 381 - 389
  • [5] Das28 responses in patients with active rheumatoid arthritis who received golimumab and methotrexate: A randomized, double-blind, placebo-controlled phase 2 trial
    Kay, J.
    Matteson, E. L.
    Dasgupta, B.
    Nash, P.
    Durezs, P.
    Hall, S.
    Han, J.
    Rahman, M. U.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 323 - 323
  • [6] Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial
    Ishiguro, Naoki
    Yamamoto, Kazuhiko
    Katayama, Kou
    Kondo, Masakazu
    Sumida, Takayuki
    Mimori, Tsuneyo
    Soen, Satoshi
    Nagai, Kota
    Yamaguchi, Tomonobu
    Hara, Masako
    MODERN RHEUMATOLOGY, 2013, 23 (03) : 430 - 439
  • [7] Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate - A randomized, double-blind, placebo-controlled trial
    Kremer, JM
    Genovese, MC
    Cannon, GW
    Caldwell, JR
    Cush, JJ
    Furst, DE
    Luggen, ME
    Keystone, E
    Weisman, MH
    Bensen, WM
    Kaine, JL
    Ruderman, EM
    Coleman, P
    Curtis, DL
    Kopp, EJ
    Kantor, SM
    Waltuck, J
    Lindsley, HB
    Markenson, JA
    Strand, V
    Crawford, B
    Fernando, I
    Simpson, K
    Bathon, JM
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (09) : 726 - 733
  • [8] Efficacy and safety results from a Phase 3, randomized, placebo-controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy
    Li, Zhanguo
    Zhang, Fengchun
    Kay, Jonathan
    Fei, Kaiyin
    Han, Chenglong
    Zhuang, Yanli
    Wu, Zhong
    Hsia, Elizabeth C.
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1143 - 1156
  • [9] Fatigue Is an Independent Variable Predicting Physical Function and Disease Activity Score-28 Remission for Patients with Rheumatoid Arthritis Treated with Intravenously Administered Golimumab: Results From Phase 3, Placebo Controlled Clinical Trial
    Westhovens, Rene
    Weinblatt, Michael
    Han, Chenglong
    Gathany, Tim
    Kim, Lilianne
    Mack, Michael
    Lu, Jiandong
    Baker, Daniel
    Mendelsohn, Alan
    Bingham, Clifton O.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S554 - S554
  • [10] The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
    Emery, P
    Fleischmann, R
    Filipowicz-Sosnowska, A
    Schechtman, J
    Szczepanski, L
    Kavanaugh, A
    Racewicz, AJ
    Van Vollenhoven, RF
    Li, NF
    Agarwal, S
    Hessey, EW
    Shaw, TM
    ARTHRITIS AND RHEUMATISM, 2006, 54 (05): : 1390 - 1400
12345